Efficacy and Safety of Alemtuzumab Through 9 Years of Follow-Up in Patients with Highly Active Disease: Post Hoc Analysis of Care-Ms I and Ii Patients in the Topaz Extension Study
AuthID
P-00S-HB9
P-00S-HB9